Search Results - "Boki, K"

Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis by TZELEPIS, G. E, KOKOSI, M, TZIOUFAS, A, TOYA, S. P, BOKI, K. A, ZORMPALA, A, MOUTSOPOULOS, H. M

“…We sought to determine the type of pulmonary involvement in microscopic polyangiitis (MPA), primarily focusing on pulmonary fibrosis (PF), its prevalence,…”
Get full text

Lupus nephritis: treatment with mycophenolate mofetil by Kapitsinou, P. P., Boletis, J. N., Skopouli, F. N., Boki, K. A., Moutsopoulos, H. M.

“…Objective. To evaluate the safety and efficacy of mycophenolate mofetil (MMF) treatment in patients with lupus nephritis. Methods. Eighteen patients with…”
Get full text

Is the heart affected in primary Sjogren's syndrome? An echocardiographic study by VASSILIOU, V. A, MOYSSAKIS, I, BOKI, K. A, MOUTSOPOULOS, H. M

“…To evaluate whether patients with primary Sjögren's syndrome without overt cardiac disease have echocardiographic abnormalities and their relation with…”
Get full text

The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease by Tzioufas, A G, Tzortzakis, N G, Panou-Pomonis, E, Boki, K A, Sakarellos-Daitsiotis, M, Sakarellos, C, Moutsopoulos, H M

“…OBJECTIVES To develop an enzyme linked immunosorbent assay (ELISA) using as substrate a synthetic 22-aminoacid peptide, corresponding to the ribosomal P0, P1…”
Get full text

Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide by Ioannidis, John P.A., Boki, Kyriaki A., Katsorida, Maria E., Drosos, Alexandros A., Skopouli, Fotini N., Boletis, John N., Moutsopoulos, Haralampos M.

“…Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Long-term intravenous cyclophosphamide (IVC) in…”
Get full text

Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy by Tzelepis, G E, Kalliakosta, G, Tzioufas, A G, Sfikakis, P P, Mandros, C, Boki, K A, Roussos, C, Moutsopoulos, H M

“…To assess the relationship between thoracoabdominal motion during quiet breathing and standardised indices of disease severity in patients with ankylosing…”
Get more information

Risk factors for central nervous system involvement in systemic lupus erythematosus by KARASSA, F.B., IOANNIDIS, J.P.A., TOULOUMI, G., BOKI, K.A., MOUTSOPOULOS, H.M.

“…We investigated risk factors for central nervous system (CNS) involvement in systemic lupus erythematosus (SLE), in 32 such patients individually matched 1 : 3…”
Get full text

Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis by Boletis, John N, Ioannidis, John PA, Boki, Kyriaki A, Moutsopoulos, Haralampos M

“…Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard…”
Get full text

Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis by Moyssakis, I., Gialafos, E., Vassiliou, V. A., Boki, K., Votteas, V., Sfikakis, P. P., Tzelepis, G. E.

“…Objective: To measure aortic stiffness and global left ventricular (LV) function in patients with ankylosing spondylitis (AS) and no clinical evidence of heart…”
Get full text

Genetic polymorphism of IL-12 p40 gene in immune-mediated disease by Hall, M A, McGlinn, E, Coakley, G, Fisher, S A, Boki, K, Middleton, D, Kaklamani, E, Moutsopoulos, H, Loughran, Jr, T P, Ollier, W E, Panayi, G S, Lanchbury, J S

“…Understanding of the genetic basis of autoimmune diseases is currently incomplete. Cytokine gene polymorphisms warrant consideration as factors explaining…”
Get full text

Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome by Tektonidou, M G, Ioannidis, J P A, Moyssakis, I, Boki, K A, Vassiliou, V, Vlachoyiannopoulos, P G, Kyriakidis, M K, Moutsopoulos, H M

“…OBJECTIVE To evaluate the prevalence of diastolic dysfunction in patients with anticardiolipin antibodies (aCL) and to examine whether the antiphospholipid…”
Get full text

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome by Tektonidou, M.G., Ioannidis, J.P.A., Boki, K.A., Vlachoyiannopoulos, P.G., Moutsopoulos, H.M.

“…We assessed whether initial clinical presentations suggestive of antiphospholipid syndrome (APS) predicted the subsequent rate and type of serious clinical…”
Get full text

Evidence-based recommendations for the management of ankylosing spondylitis : results of the Hellenic working group of the 3E Initiative in Rheumatology by RAPTOPOULOU, A, SIDIROPOULOS, P, BOUMPAS, D. T, SIAKKA, P, BOKI, K, DROSOS, A. A, ASLANIDIS, S, KARRAS, D, PIKAZIS, D, VASSILOPOULOS, D, KARASSA, F

“…The 3E (Evidence, Experts and Exchange) Initiative is a multi-national effort that involves a large number of experts and practicing rheumatologists addressing…”
Get full text

Acute hepatitis following mycophenolate mofetil administration for ANCA-positive vasculitis by Dourakis, S. P., Boki, K., Soultati, AS, Cherouvim, EP, Delladetsima, I.

Get full text

Infliximab Therapy for Patients With Active and Refractory Spondyloarthropathies at the Dose of 3 mg/kg: A 20-Month Open Treatment by Cherouvim, E P, Zintzaras, E, Boki, K A, Moutsopoulos, H M, Manoussakis, M N

“…BACKGROUND:Infliximab at the dose of 5 mg/kg per infusion has been shown effective for the treatment of active spondyloarthropathies. It is not clear if the 5…”
Get full text

How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study by BOKI, Kyriaki A, IOANNIDIS, John P. A, SEGAS, John V, MARAGKOUDAKIS, Pavlos V, PETROU, Dimitrios, ADAMOPOULOS, George K, MOUTSOPOULOS, Haralampos M

“…We evaluated whether sensorineural loss and vestibular abnormalities are common in patients with primary Sjögren's syndrome (pSS) and whether such…”
Get full text

Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus by Karassa, F B, Ioannidis, J P, Boki, K A, Touloumi, G, Argyropoulou, M I, Strigaris, K A, Moutsopoulos, H M

“…We sought to identify the predictors of clinical outcome and of the evolution of cerebral abnormalities in patients with neuropsychiatric systemic lupus…”
Get more information

Pure red cell aplasia as presentation of systemic lupus erythematosus : Antibodies to erythropoietin by LINARDAKI, G. D, BOKI, K. A, FERTAKIS, A, TZIOUFAS, A. G

“…In this case report we describe two patients with pure red cell aplasia (PRCA) as an initial manifestation of systemic lupus erythematosus (SLE). Antibodies to…”
Get full text

Hemoptysis as the first symptom of limited cutaneous systemic sclerosis by Pasalidou, E, Tzavara, V, Vondetsianos, Ch, Boki, K

Get full text

Thrombotic thrombocytopenic purpura in adult Still's disease by Boki, K A, Tsirantonaki, M J, Markakis, K, Moutsopoulos, H M

“…We describe 2 patients with adult Still's disease who developed thrombotic thrombocytopenic purpura (TTP) and were successfully treated. Although TTP has been…”
Get more information